Turnstone Biologics Announces US FDA Acceptance of IND for Immunotherapy Targeting HPV Positive Cancers – Business Wire (press release)
Business Wire (press release) |
Turnstone Biologics Announces US FDA Acceptance of IND for Immunotherapy Targeting HPV Positive Cancers
Business Wire (press release) NEW YORK & OTTAWA, Ontario–(BUSINESS WIRE)–Turnstone Biologics today announced it has received U.S. Food and Drug Administration (FDA) clearance of its Investigational New Drug Application (IND) for MG1-HPV for the treatment of patients with … |
